The upcoming Global Bio-India (GBI) 2023, scheduled from December 4th to 6th in New Delhi, aims to serve as a significant platform uniting major industries, biotech stakeholders, investors, and startups for networking opportunities. The central theme for this third edition is "Transforming Lives: Biosciences to Bioeconomy". Organized by the Department of Biotechnology (DBT), Ministry of Science and Technology (MoST), Government of India, in collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), a PSU, the event will also feature a public session titled "Science Connect Series with Society". This session will host global experts from healthcare, AI, and life sciences domains.

Dr. Jitendra Kumar, Managing Director at BIRAC, highlighted that the upcoming third edition of Global Bio-India presents an excellent opportunity to showcase India's biotechnology sector to the global community. The event aims to identify prospects, address challenges, and foster collaborations within the biotech industry. With participation expected from over 30 countries, a strong presence of innovators and startups is anticipated. Specific pavilions will be dedicated to incubators, state representations and startups, including a themed pavilion featuring successful BIRAC startups.

He also mentioned that the summit will host CEO Roundtables involving multinational companies from biopharma, medtech, diagnostics, industrial biotech, and bio-agri sectors. Discussions will focus on national and global regulatory trends, with sessions dedicated to biomanufacturing and the biotech innovation ecosystem. The event will facilitate interactions between academia and industry, engaging major industry associations, investor groups, and global entrepreneurship organizations through debates, dialogues, and audience interactions. The event will showcase over 300 exhibits by successful Biotech Startups/SMEs, more than a hundred biotech incubation centers, and the participation of 30 large industries and services CROs. Ten states will be actively promoting their biotech policies. Additionally, more than 25 universities and research institutions, along with over 40 startups, will have opportunities to engage with potential investors.